Featured

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

North America Session – From reaction to result: Connecting chemistry and biology for smarter drug discovery

A molecule passes through many hands in drug discovery. Medicinal chemists design and synthesise it, analytical scientists characterise it, and biology teams evaluate its activity. Yet the scientific knowledge generated along the way often remains fragmented across disconnected systems, making it difficult to connect what was made, how it was… Read More

Webinar date:
Supported by Benchling
#Featured Webinars #Webinars

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

Europe Session – From reaction to result: Connecting chemistry and biology for smarter drug discovery

A molecule passes through many hands in drug discovery. Medicinal chemists design and synthesise it, analytical scientists characterise it, and biology teams evaluate its activity. Yet the scientific knowledge generated along the way often remains fragmented across disconnected systems, making it difficult to connect what was made, how it was… Read More

Webinar date:
Supported by Benchling
#Featured Webinars #Webinars

#Biomarkers #Drug discovery #Evotec #Immunoassays #Webinar

Measuring what matters: Applying ultrasensitive immunoassays for clinical biomarkers

When biomarkers are present at very low concentrations, conventional immunoassays may not provide the sensitivity needed to generate reliable, meaningful data. This can limit the ability to assess target engagement, monitor pharmacodynamic responses and track biomarker changes during treatment. Ultrasensitive immunoassays offer new opportunities to address these challenges. In this… Read More

Webinar date:
Supported by Evotec
#Featured Webinars #Webinars

#Crown Bioscience #Drug discovery #PDX models #Webinar

Beyond the model: Exploring warm PDX benefits and onsite expertise

Patient-derived xenograft (PDX) models are a valuable tool in oncology research, helping researchers evaluate therapeutic efficacy in preclinical settings using models that retain key characteristics of human tumours. In this webinar, Crown Bioscience will highlight the capabilities of its PDX model portfolio, with a particular focus on the benefits of… Read More

Webinar date:
Supported by Crown Bioscience
#Featured Webinars #Webinars

#Biomarkers #Drug discovery #Evotec #Webinar

From PK/PD and Biomarkers to decision-making: How modeling shapes clinical strategy

Clinical trials continue to experience high attrition rates, with lack of efficacy being one of the leading causes of failure. However, in many cases, these failures do not reflect a lack of drug efficacy, but rather limitations in translational biomarker strategies and selection of disease-relevant pharmacodynamic (PD) biomarkers, suboptimal dose… Read More

Webinar date:
Supported by Evotec
#Featured Webinars #Webinars

Cell and gene therapy
#Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy

Advances and challenges in cell and gene therapies

Hosted by Drug Discovery World and supported by Bio-Techne, this webinar explores the advances and challenges taking place within the cell and gene therapy field. Hear from Hans Schambye CEO at BOOST Pharma, Lucas Arruda, CSO at CuraCell, and Brandon Cieniewicz, Director, Research & Development at CERo Therapeutics. Throughout the… Read More

Webinar date:
Sponsored by Bio-Techne
#Featured Webinars

Webinars

#AI / data analytics / healthtech / informatics #Cloud computing #Drug discovery #Webinar

From lead optimisation to drug candidate triage: A data-driven approach to drug discovery

Embark on an in-depth journey through the pivotal Make-Test-Decide Workflow, where collaboration and data-driven decisions play a paramount role in the intricate landscape of drug discovery. This on-demand webinar shows how cloud implementation fosters accessibility and collaboration, revolutionising research across locations and companies. This presentation illustrates: The use of the… Read More

Webinar date:
Brought to you by Revvity Signals
#Webinars

Scientific research
#Drug discovery #In vitro #mRNA #Webinar

Scaling up in vitro transcription: Key results and considerations

In vitro transcription (IVT) can be a complicated reaction. Scaling up this process requires a good understanding of the various reaction parameters that need to be optimised and controlled to give the best result in terms of mRNA yields and quality. In this presentation, a review of the results from scaling… Read More

Webinar date:
Supported by Thermo Fisher Scientific
#Webinars

Active nerve cells
#Drug discovery #Neurodegenerative disorders #Neuroinflammation #Neurology #Neuroscience #Webinar

Innovative advances in neuroscience

In this webinar, hosted by DDW and sponsored by ACROBiosystems, you will learn about the innovative advances in neuroscience. You will hear from Fiona Elwood, VP, Disease Area Stronghold Lead, Neurodegeneration, Janssen, and Jenny Barnett, CEO of Monument TX, as well as Rosanna Zhang, Vice President of Corporate Development at… Read More

Webinar date:
Sponsored by ACROBiosystems
#Webinars

#AI / data analytics / healthtech / informatics #Drug discovery #Generative AI #Webinar

Generative AI: Turning drug discovery into a technological pursuit

This webinar, supported by Thermo Fisher Scientific and presented by Generate:Biomedicines, is now available to view on-demand. The webinar, hosted by DDW, will feature the expertise of Adam Root, Vice President, Protein Sciences at Generate:Biomedicines who will discuss how an integrated approach of using Cryo-EM with ML methods has the… Read More

Webinar date:
Supported by Thermo Fisher Scientific
#Webinars

Future lab, AI and digital data
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Lab automation #Machine learning #Webinar

AI & Lab Automation: What are the key benefits and latest innovations?

In this webinar, hosted by DDW and co-sponsored by Benchling and Proscia, you will learn about the key benefits and latest innovations to be aware of in AI and lab automation. You will hear from Jeremy Skillington, CEO of Poolbeg Pharma, as well as sponsor presentations from Helen Liu-Mayo, Product… Read More

Webinar date:
Co-sponsored by Benchling and Proscia
#Webinars

Pluripotent stem cells
#Human disease models #iPSC #Liver disease #Preclinical investigations #Stem cells #Webinar

Discover how iPSC derived cells can be used to support the development of drug and gene therapies

A considerable roadblock in the successful triaging of new therapeutics for liver and metabolic related diseases is the reliability and effectiveness of pre-clinical disease models. Methods employing animal models may have limited success in replicating liver diseases, primarily because of species-specific differences, furthermore, the utilisation of animal models to simulate… Read More

Webinar date:
Supported by DefiniGEN
#Webinars

RNA
#Covid-19 #RNA #RNA sequencing #Roundtable

What are some of the biggest challenges related to the development & delivery of RNA therapeutics?

In this roundtable, moderated by DDW and sponsored by Azenta Life Sciences, learn about the biggest challenges related to the delivery of RNA therapeutics. Roundtable panellists include Dr Philip Cruz, UK Medical Director, Moderna, Dr Neill Liptrott, Reader in Pharmacology and Immuno-compatability, University of Liverpool, and Reece Armstrong, Editor, DDW. Read More

Webinar date:
Sponsored by Azenta Life Sciences
#Webinars

Medical research
#ADME / Tox #Drug development #Drug discovery #Regulatory

Are in vitro metabolism and drug-drug interaction studies critical for an investigational new drug application?

In vitro ADME and drug-drug interaction (DDI) investigations are early activities in the drug development process that are critical for framing downstream decision making. Understanding the ADME properties and DDI risks of your compound helps you avoid unnecessary clinical studies, costs, delays and more. This webinar will provide insights at… Read More

Webinar date:
Supported by BioIVT
#Webinars

mRNA
#Drug development #Drug discovery #mRNA #mRNA-based vaccines

Where are the breakthroughs in mRNA drug discovery and development?

In this on demand webinar, hosted by DDW and sponsored by Elegen, learn about the breakthroughs in mRNA drug discovery and development. You will hear from Carsten Rudolph, Managing Director and CEO of Ethris, Klaas Zuideveld, CEO of Versameb, as well as Matthew Hill, Founder and CEO of Elegen. What… Read More

Webinar date:
Sponsored by Elegen
#Webinars

AAV
#AAV #Azenta Life Sciences #Drug development #Drug discovery #Gene therapy #Plasmid DNA

A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy

AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers. In this webinar, supported by Azenta Life Sciences, we’ll help you understand the AAV workflow, from upstream methods for AAV production and validation to downstream analysis of the… Read More

Webinar date:
Brought to you by Azenta Life Sciences
#Webinars

Laboratory equipment
#Human disease models #Humanised Immune System (HIS) #Stem cells #The Jackson Laboratory

Comparing immune-humanized platforms: Which one is best for my application?

Humanization of highly immunodeficient NSG mice with hematopoietic stem cells or peripheral blood mononuclear cells provides a powerful platform for very precise modeling of human immune responses. These immune-humanized platforms enable researchers to test a wide range of human-specific therapeutic approaches developed to either up or down regulate immune function. Read More

Webinar date:
Brought to you by The Jackson Laboratory
#Webinars

Drug discovery
#Antibody drug conjugate (ADC) #Artificial intelligence (AI) #Cell and gene therapy #Drug development #Drug discovery #mRNA-based vaccines

Drug discovery and development trends – what will have most impact?

Hosted by DDW and sponsored by DNA Script, watch this free roundtable on demand to learn about the biggest opportunities for the future of drug discovery and development. Roundtable panellists include Commercial Research Scientist, Dr Mark Treherne, CEO of Elevation Oncology, Joe Ferra, and CEO of BioXcel… Read More

Webinar date:
Sponsored by DNA Script
#Webinars

Cancer immunotherapy
#Cancer immunotherapy #Cancer research #Cell therapy #Immunotherapy #Oncology #Personalised medicine

Cancer immunotherapy – where will the future opportunities be?

Watch this free webinar to learn about the biggest opportunities for the future of cancer immunotherapy.   In this free webinar, you will hear from immunologist Dr Frédéric Triebel, CSO and CMO of Immutep, two experts from DeciBio: Dr Carl Schoellhammer, Principal, and Dr Joe Daccache, Senior Life… Read More

Webinar date:
Brought to you by BPS BioScience and AcroBiosystems
#Webinars

#Agilent #Mitochondria #Neurodegenerative disorders #Neurology #Rare disease

Neuronal metabolism and its impact on early drug discovery

CLN7 neuronal ceroid lipofuscinosis is an inherited lysosomal storage neurodegenerative disease highly prevalent in children. In her webinar, Dr García Macía discusses how failure in autophagy causes the accumulation of structurally and bioenergetically impaired neuronal mitochondria in the mouse model of CLN7 disease, and how the mitochondrial reactive oxygen species… Read More

Webinar date:
Brought to you by Agilent
#Webinars

Genetic sequencing
#Cancer research #Genetics / genomics #Next generation sequencing #Oncology #Personalised medicine #RNA sequencing #The Tecan Group

How next-generation sequencing is informing oncology drug discovery

Watch this free webinar to learn about the biggest challenges and opportunities facing the NGS oncology space.   You will hear from Darrell Green, a lecturer in RNA Biology at Norwich Medical School, Panna Sharma, CEO of Lantern Pharma, as well as Dr Stephane Budel and Dr… Read More

Webinar date:
Brought to you by Tecan
#Webinars

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry

Connected chemistry: How to choose the most promising drug candidates from your hit list

AI and machine learning (AI/ML) methods offer an alluring way to expedite the drug discovery process by delivering a large number of possible new candidates for any given therapeutic area. However, insight from medicinal chemists is still necessary to triage and prioritise the most promising molecules for synthesis, and progress… Read More

Webinar date:
Sponsored by Torx Software
#Webinars